Forum Financial Management’s Agilent Technologies A Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,068
Closed -$417K 333
2025
Q4
$417K Buy
3,068
+147
+5% +$21.1K 0.01% 574
2025
Q3
$375K Buy
2,921
+70
+2% +$8.46K 0.01% 606
2025
Q2
$336K Sell
2,851
-442
-13% -$49K 0.01% 607
2025
Q1
$385K Sell
3,293
-149
-4% -$20.1K 0.01% 467
2024
Q4
$462K Buy
3,442
+1,025
+42% +$140K 0.01% 405
2024
Q3
$359K Buy
2,417
+4
+0.2% +$548 0.01% 442
2024
Q2
$313K Buy
2,413
+2
+0.1% +$280 0.01% 461
2024
Q1
$351K Hold
2,411
0.01% 443
2023
Q4
$335K Sell
2,411
-158
-6% -$18.8K 0.01% 411
2023
Q3
$287K Hold
2,569
0.01% 433
2023
Q2
$309K Buy
2,569
+122
+5% +$15.5K 0.01% 423
2023
Q1
$339K Sell
2,447
-53
-2% -$7.75K 0.01% 365
2022
Q4
$374K Sell
2,500
-135
-5% -$19.3K 0.01% 326
2022
Q3
$320K Sell
2,635
-24
-0.9% -$3.08K 0.02% 324
2022
Q2
$316K Buy
2,659
+637
+32% +$78.3K 0.02% 338
2022
Q1
$267K Buy
2,022
+43
+2% +$5.92K 0.01% 450
2021
Q4
$316K Buy
+1,979
New +$308K 0.02% 392

Other funds holding A

Forum Financial Management's A Position: Q1 2026 in Review

Forum Financial Management sold out of Agilent Technologies (A) in Q1 2026, closing a stake of 3,068 shares — an estimated $417K sold.

Forum Financial Management first reported a position in A in Q4 2021 and held it in 17 quarters. The position peaked at $462K in Q4 2024. 1,072 funds tracked by Wall St. Rank hold A as of Q1 2026.

  • Forum Financial Management reported no remaining Agilent Technologies position as of Q1 2026 after selling out during the quarter.
  • Forum Financial Management sold 3,068 Agilent Technologies shares in Q1 2026, an estimated $417K.
  • Forum Financial Management first reported a position in Agilent Technologies in Q4 2021 and held it in 17 quarters.
  • Forum Financial Management's Agilent Technologies position peaked at $462K in Q4 2024.
  • 1,072 funds tracked by Wall St. Rank held Agilent Technologies as of Q1 2026.

Based on Forum Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.